Oral contraceptives, reproductive factors, and risk of colorectal cancer among women in a prospective cohort study

American Journal of Epidemiology

Volumn 165, Issue 7, 2007, Pages 794-801

  Lin, Jennifer ^a   Zhang, Shumin M ^a,b   Cook, Nancy R ^a,b   Manson, JoAnn E ^a,b   Buring, Julie E ^a,b,c   Lee, I Min ^a,b  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Colorectal cancer; Contraceptives, oral; Hormones; Menarche; Menopause; Parity; Women

Indexed keywords

ORAL CONTRACEPTIVE AGENT;

CANCER; COHORT ANALYSIS; CONTRACEPTIVE USE; HEALTH RISK; HEALTH SURVEY; RISK ASSESSMENT; RISK FACTOR; WOMENS HEALTH;

ADULT; ARTICLE; CANCER PREVENTION; CANCER RISK; COHORT ANALYSIS; COLORECTAL CANCER; CONFIDENCE INTERVAL; CONTROLLED STUDY; COURSE EVALUATION; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MATERNAL AGE; MENARCHE; MENOPAUSE; ORAL CONTRACEPTION; PARITY; PROPORTIONAL HAZARDS MODEL; PROSPECTIVE STUDY; REPRODUCTIVE HEALTH; RISK ASSESSMENT; RISK REDUCTION; STATISTICAL ANALYSIS; WOMEN'S HEALTH;

AGE FACTORS; COLORECTAL NEOPLASMS; CONTRACEPTIVES, ORAL; FEMALE; HUMANS; MENARCHE; MENOPAUSE; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; QUESTIONNAIRES; REPRODUCTIVE HISTORY; RISK FACTORS;

EID: 33947283114     PISSN: 00029262     EISSN: 14766256     Source Type: Journal    
DOI: 10.1093/aje/kwk068     Document Type: Article

References (63)

1. Jemal A, Siegel R, Ward E, et al. Cancer statistics, 2006. CA Cancer J Clin 2006;56:106-30.
2. Froggatt NJ, Green J, Brassett C, et al. A common MSH2 mutation in English and North American HNPCC families: origin, phenotypic expression, and sex specific differences in colorectal cancer. J Med Genet 1999;36:97-102.
3. Odagiri E, Jibiki K, Kato Y, et al. Steroid receptors in dimethylhydrazine-induced colon carcinogenesis. Cancer 1985;56:2627-34.
4. Issa JP, Ottaviano YL, Celano P, et al. Methylation of the oestrogen receptor CpG island links ageing and neoplasia in human colon. Nat Genet 1994;7:536-40.
5. Issa JP, Zehnbauer BA, Civin CI, et al. The estrogen receptor CpG island is methylated in most hematopoietic neoplasms. Cancer Res 1996;56:973-7.
6. Qiu Y, Waters CE, Lewis AE, et al. Oestrogen-induced apoptosis in colonocytes expressing oestrogen receptor beta. J Endocrinol 2002;174:369-77.
7. Foley EF, Jazaeri AA, Shupnik MA, et al. Selective loss of estrogen receptor beta in malignant human colon. Cancer Res 2000;60:245-8.
8. Campbell-Thompson M, Lynch IJ, Bhardwaj B. Expression of estrogen receptor (ER) subtypes and ERβ isoforms in colon cancer. Cancer Res 2001;61:632-40.
9. Rossouw JE, Anderson GL, Prentice RL, et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial. JAMA 2002;288:321-33.
10. Potter JD, McMichael AJ. Large bowel cancer in women in relation to reproductive and hormonal factors: a case-control study. J Natl Cancer Inst 1983;71:703-9.
11. Kampman E, Potter JD, Slattery ML, et al. Hormone replacement therapy, reproductive history, and colon cancer: a multicenter, case-control study in the United States. Cancer Causes Control 1997;8:146-58.
12. Furner SE, Davis FG, Nelson RL, et al. A case-control study of large bowel cancer and hormone exposure in women. Cancer Res 1989;49:4936-40.
13. Gerhardsson de Verdier M, London S. Reproductive factors, exogenous female hormones, and colorectal cancer by subsite. Cancer Causes Control 1992;3:355-60.
14. Martinez ME, Grodstein F, Giovannucci E, et al. A prospective study of reproductive factors, oral contraceptive use, and risk of colorectal cancer. Cancer Epidemiol Biomarkers Prev 1997;6:1-5.
15. Fernandez E, La Vecchia C, D'Avanzo B, et al. Oral contraceptives, hormone replacement therapy and the risk of colorectal cancer. Br J Cancer 1996;73:1431-5.
16. Fernandez E, La Vecchia C, Franceschi S, et al. Oral contraceptive use and risk of colorectal cancer. Epidemiology 1998;9:295-300.
17. Nichols HB, Trentham-Dietz A, Hampton JM, et al. Oral contraceptive use, reproductive factors, and colorectal cancer risk: findings from Wisconsin. Cancer Epidemiol Biomarkers Prev 2005;14:1212-18.
18. Hannaford P, Elliott A. Use of exogenous hormones by women and colorectal cancer: evidence from the Royal College of General Practitioners' Oral Contraception Study. Contraception 2005;71:95-8.
19. Peters RK, Pike MC, Chang WW, et al. Reproductive factors and colon cancers. Br J Cancer 1990;61:741-8.
20. Wu-Williams AH, Lee M, Whittemore AS, et al. Reproductive factors and colorectal cancer risk among Chinese females. Cancer Res 1991;51:2307-11.
21. Kune GA, Kune S, Watson LF. Children, age at first birth, and colorectal cancer risk. Data from the Melbourne Colorectal Cancer Study. Am J Epidemiol 1989;129:533-42.
22. Weiss NS, Daling JR, Chow WH. Incidence of cancer of the large bowel in women in relation to reproductive and hormonal factors. J Natl Cancer Inst 1981;67:57-60.
23. Jacobs EJ, White E, Weiss NS. Exogenous hormones, reproductive history, and colon cancer (Seattle, Washington, USA). Cancer Causes Control 1994;5:359-66.
24. Troisi R, Schairer C, Chow WH, et al. A prospective study of menopausal hormones and risk of colorectal cancer (United States). Cancer Causes Control 1997;8:130-8.
25. Bostick RM, Potter JD, Kushi LH, et al. Sugar, meat, and fat intake, and non-dietary risk factors for colon cancer incidence in Iowa women (United States). Cancer Causes Control 1994;5:38-52.
26. Risch HA, Howe GR. Menopausal hormone use and colorectal cancer in Saskatchewan: a record linkage cohort study. Cancer Epidemiol Biomarkers Prev 1995;4:21-8.
27. Davis FG, Furner SE, Persky V, et al. The influence of parity and exogenous female hormones on the risk of colorectal cancer. Int J Cancer 1989;43:587-90.
28. Kampman E, Bijl AJ, Kok C, et al. Reproductive and hormonal factors in male and female colon cancer. Eur J Cancer Prev 1994;3:329-36.
29. Broeders MJ, Lambe M, Baron JA, et al. History of child-bearing and colorectal cancer risk in women aged less than 60: an analysis of Swedish routine registry data 1960-1984. Int J Cancer 1996;66:170-5.
30. Marcus PM, Newcomb PA, Young T, et al. The association of reproductive and menstrual characteristics and colon and rectal cancer risk in Wisconsin women. Ann Epidemiol 1995;5:303-9.
31. Slattery ML, Mineau GP, Kerber RA. Reproductive factors and colon cancer: the influences of age, tumor site, and family history on risk (Utah, United States). Cancer Causes Control 1995;6:332-8.
32. Ghadirian P, Maisonneuve P, Perret C, et al. Epidemiology of sociodemographic characteristics, lifestyle, medical history, and colon cancer: a case-control study among French Canadians in Montreal. Cancer Detect Prev 1998;22:396-404.
33. Kravdal O, Glattre E, Kvale G, et al. A sub-site-specific analysis of the relationship between colorectal cancer and parity in complete male and female Norwegian birth cohorts. Int J Cancer 1993;53:56-61.
34. Chute CG, Willett WC, Colditz GA, et al. A prospective study of reproductive history and exogenous estrogens on the risk of colorectal cancer in women. Epidemiology 1991;2:201-7.
35. Byers T, Graham S, Swanson M. Parity and colorectal cancer risk in women. J Natl Cancer Inst 1982;69:1059-62.
36. Papadimitriou C, Day N, Tzonou A, et al. Biosocial correlates of colorectal cancer in Greece. Int J Epidemiol 1984;13:155-9.
37. Negri E, La Vecchia C, Parazzini F, et al. Reproductive and menstrual factors and risk of colorectal cancer. Cancer Res 1989;49:7158-61.
38. Franceschi S, Bidoli E, Talamini R, et al. Colorectal cancer in northeast Italy: reproductive, menstrual and female hormone-related factors. Eur J Cancer 1991;27:604-8.
39. Howe GR, Craib KJ, Miller AB. Age at first pregnancy and risk of colorectal cancer: a case-control study. J Natl Cancer Inst 1985;74:1155-9.
40. Plesko I, Preston-Martin S, Day NE, et al. Parity and cancer risk in Slovakia. Int J Cancer 1985;36:529-33.
41. Kvale G, Heuch I. Is the incidence of colorectal cancer related to reproduction? A prospective study of 63,000 women. Int J Cancer 1991;47:390-5.
42. Yoo KY, Tajima K, Inoue M, et al. Reproductive factors related to the risk of colorectal cancer by subsite: a case-control analysis. Br J Cancer 1999;79:1901-6.
43. Talamini R, Franceschi S, Dal Maso L, et al. The influence of reproductive and hormonal factors on the risk of colon and rectal cancer in women. Eur J Cancer 1998;34:1070-6.
44. La Vecchia C, Lucchini F, Negri E, et al. Trends of cancer mortality in Europe, 1955-1989: I. Digestive sites. Eur J Cancer 1992;28:132-235.
45. Jacobson JS, Neugut AI, Garbowski GC, et al. Reproductive risk factors for colorectal adenomatous polyps (New York City, NY, United States). Cancer Causes Control 1995;6:513-18.
46. Ridker PM, Cook NR, Lee IM, et al. A randomized trial of low-dose aspirin in the primary prevention of cardiovascular disease in women. N Engl J Med 2005;352:1293-304.
47. Lee IM, Cook NR, Gaziano JM, et al. Vitamin E in the primary prevention of cardiovascular disease and cancer: the Women's Health Study: a randomized controlled trial. JAMA 2005;294:56-65.
48. Cook NR, Lee IM, Gaziano JM, et al. Low-dose aspirin in the primary prevention of cancer: the Women's Health Study: a randomized controlled trial. JAMA 2005;294:47-55.
49. McMichael AJ, Potter JD. Reproduction, endogenous and exogenous sex hormones, and colon cancer: a review and hypothesis. J Natl Cancer Inst 1980;65:1201-7.
50. Fernandez E, La Vecchia C, Balducci A, et al. Oral contraceptives and colorectal cancer risk: a meta-analysis. Br J Cancer 2001;84:722-7.
51. Singh S, Langman MJ. Oestrogen and colonic epithelial cell growth. Gut 1995;37:737-9.
52. Narisawa T, Magadia NE, Weisburger JH, et al. Promoting effect of bile acids on colon carcinogenesis after intrarectal instillation of N-methyl-N′-nitro-N-nitrosoguanidine in rats. J Natl Cancer Inst 1974;53:1093-7.
53. McMichael AJ, Potter JD. Host factors in carcinogenesis: certain bile-acid metabolic profiles that selectively increase the risk of proximal colon cancer. J Natl Cancer Inst 1985;75:185-91.
54. Everson GT, McKinley C, Kern F Jr. Mechanisms of gallstone formation in women. Effects of exogenous estrogen (Premarin) and dietary cholesterol on hepatic lipid metabolism. J Clin Invest 1991;87:237-46.
55. Anderson GL, Limacher M, Assaf AR, et al. Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women's Health Initiative randomized controlled trial. JAMA 2004;291:1701-12.
56. Baird DT, Glasier AF. Hormonal contraception. N Engl J Med 1993;328:1543-9.
57. Marchbanks PA, McDonald JA, Wilson HG, et al. Oral contraceptives and the risk of breast cancer. N Engl J Med 2002;346:2025-32.
58. Turgeon JL, McDonnell DP, Martin KA, et al. Hormone therapy: physiological complexity belies therapeutic simplicity. Science 2004;304:1269-73.
59. Vongpatanasin W, Tuncel M, Wang Z, et al. Differential effects of oral versus transdermal estrogen replacement therapy on C-reactive protein in postmenopausal women. J Am Coll Cardiol 2003;41:1358-63.
60. Giovannucci E, Pollak MN, Platz EA, et al. A prospective study of plasma insulin-like growth factor-1 and binding protein-3 and risk of colorectal neoplasia in women. Cancer Epidemiol Biomarkers Prev 2000;9:345-9.
61. Sutton-Tyrrell K, Wildman RP, Matthews KA, et al. Sex hormone-binding globulin and the free androgen index are related to cardiovascular risk factors in multiethnic premenopausal and perimenopausal women enrolled in the Study of Women Across the Nation (SWAN). Circulation 2005;111:1242-9.
62. Chang CK, Ulrich CM. Hyperinsulinaemia and hyperglycaemia: possible risk factors of colorectal cancer among diabetic patients. Diabetologia 2003;46:595-607.
63. Newcomb PA, Storer BE. Postmenopausal hormone use and risk of large-bowel cancer. J Natl Cancer Inst 1995;87:1067-71.